Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and
one of the major causes of blindness worldwide. The pathogenesis of DR has been …

Purpose. Recent evidence has shown that retinal inflammation is a key player in diabetic
retinopathy (DR) pathogenesis. To further understand and validate the metabolic biomarkers …

Diabetic retinopathy (DR) is one of the major complications of diabetic eye diseases,
causing vision loss and blindness worldwide. The concept of diabetic retinopathy has …

Purpose To investigate the expression of Glucagon-like peptide-1 receptor (GLP-1R),
sodium-glucose co-transporter (SGLT) 1, SGLT2, Glucose transporter type 1 (GLUT1) and …

Aims Retinopathy is a neurodegenerative complication associating diabetes mellitus.
Diabetic retinopathy (DR) is the primary reason of visual loss during early adulthood. DR …

In diabetic retinopathy, high glucose (HG)-mediated breakdown in cell-cell communication
promotes disruption of retinal homeostasis. Several studies indicate that HG condition alters …

Diabetic retinopathy (DR) is the most common complication that develops in patients with
diabetes mellitus (DM) and is the leading cause of blindness worldwide. Fortunately, sight …

Background Diabetic retinopathy is characterized by defects in the retinal neurovascular
unit. The underlying mechanisms of impairment–including reactive intermediates and …

Diabetes mellitus is a chronic metabolic disease that occurs when the pancreas is not
producing enough insulin or when the insulin that it does produce is not able to be used …

Purpose To define gene expression changes associated with diabetic retinopathy in a
mouse model using next generation sequencing, and to utilize transcriptome signatures to …